MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
Starting soon · Phase 4 · Has a placebo group
Conditions studied: Diabetes, Kidney Disease, Vascular Disease, Retinopathy
In brief
Diabetes mellitus type 2 is associated with significant morbidity and mortality; and identifying new treatments for diabetes complications to be used alone or in combination with other therapies is a high priority. Hyperglycemia triggers proinflammatory pathways leading to damage in the kidneys, eyes and blood vessels; thus targeting proinflammatory lipid mediators called leukotrienes may represent a promising therapy for diabetes complications. This clinical trial seeks to investigate whether montelukast, a leukotriene antagonist, improves kidney, eye and vascular function in adult participants with type 2 diabetes and kidney disease.
Key facts
- Study ID
- NCT07685886
- Run by
- University of Colorado, Denver
- People needed
- 110
- Starts
- 2026-09-01
- Expected to finish
- 2031-08-31
- Last updated by the study team
- 2026-07-06
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diabetes type 2
- Urine albumin to creatinine ratio 30-5000 mg/g
- CKD stage 2-3 (eGFR 30-89 ml/min/1.73m2)
- Blood pressure < 140/90 mmHg prior to randomization
- BMI < or = to 40 kg/m2
- Use of ACEi or ARB with stable dose for 4 weeks
- if on SGLT2i or GLP-1RA, stable dose for 3 months prior to baseline
- Able to provide consent
You may not qualify if…
- Type 1 diabetes
- Uncontrolled hypertension
- Hemoglobin A1C >10%
- Pregnancy or planning to become pregnant or currently breastfeeding
- Allergy to aspirin
- History of major psychiatric disorder
- Use of inhaled or systemic corticosteroids or long-acting beta agonists
- Proliferative retinopathy requiring current treatment
Where it is running
- University of Colorado Denver — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.